just a bit of background reading
http://csmres.co.uk/cs.public.upd/article-downloads/Cipolla_2011-2012_Drug-Discovery-Today-Therapeutic-Strategies.pdf
Describes the benefits of inhaled delivery via metered dose.
"The inhalation route maximizes the delivered dose to the
respiratory tract while minimizing the dose delivered to the
rest of the body where it may serve no useful purpose and has
the potential to cause side effects. Inhalation delivery is
therefore more often superior for the treatment of respiratory diseases than other routes of administration"
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.010(9.09%) |
Mkt cap ! $8.487M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.5¢ | $22.12K | 221.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 106737 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 732 | 1 |
View Market Depth
| Last trade - 13.05pm 30/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |